AnaptysBio Inc [NASDAQ: ANAB] price surged by 30.51 percent to reach at $3.77.
The one-year ANAB stock forecast points to a potential upside of 52.63. The average equity rating for ANAB stock is currently 1.50, trading closer to a bullish pattern in the stock market.
Guru’s Opinion on AnaptysBio Inc [ANAB]:
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for ANAB shares is $34.09 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on ANAB stock is a recommendation set at 1.50. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Wolfe Research have made an estimate for AnaptysBio Inc shares, keeping their opinion on the stock as Outperform, with their previous recommendation back on February 04, 2025. While these analysts kept the previous recommendation, H.C. Wainwright dropped their target price from $52 to $19. The new note on the price target was released on December 11, 2024, representing the official price target for AnaptysBio Inc stock.
The Average True Range (ATR) for AnaptysBio Inc is set at 1.51, with the Price to Sales ratio for ANAB stock in the period of the last 12 months amounting to 8.60. The Price to Book ratio for the last quarter was 5.82, with the Price to Cash per share for the same quarter was set at 14.14.
ANAB Stock Performance Analysis:
AnaptysBio Inc [ANAB] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.56. With this latest performance, ANAB shares gained by 10.47% in over the last four-week period, additionally sinking by -52.15% over the last 6 months – not to mention a drop of -29.81% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for ANAB stock in for the last two-week period is set at 50.83, with the RSI for the last a single of trading hit 53.39, and the three-weeks RSI is set at 48.44 for AnaptysBio Inc [ANAB]. The present Moving Average for the last 50 days of trading for this stock 16.67, while it was recorded at 14.44 for the last single week of trading, and 26.22 for the last 200 days.
Insight into AnaptysBio Inc Fundamentals:
AnaptysBio Inc’s liquidity data is similarly interesting compelling, with a Quick Ratio of 10.23 and a Current Ratio set at 10.23.
ANAB Stock EPS
The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for ANAB. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for AnaptysBio Inc go to 4.69%.
AnaptysBio Inc [ANAB] Institutonal Ownership Details
There are presently around $118.56%, or 120.65%% of ANAB stock, in the hands of institutional investors. The top three institutional holders of ANAB stocks are: ECOR1 CAPITAL, LLC with ownership of 7.52 million shares, which is approximately 27.4931%. FMR LLC, holding 2.87 million shares of the stock with an approximate value of $$71.94 million in ANAB stocks shares; and FMR LLC, currently with $$54.27 million in ANAB stock with ownership which is approximately 7.9163%.
